AI assistant
Natera, Inc. — Director's Dealing 2021
Nov 4, 2021
30253_dirs_2021-11-03_b414f891-74d9-4a19-af10-fd3d2fddb2d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2021-11-01
Reporting Person: Schueren Robert Alan (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-01 | Common Stock | M | 6000 | $13.01 | Acquired | 27897 | Direct |
| 2021-11-01 | Common Stock | S | 6000 | $120 | Disposed | 21897 | Direct |
| 2021-11-01 | Common Stock | S | 6000 | $120.0016 | Disposed | 15897 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-01 | Stock Option (right to buy) | $13.01 | M | 6000 | Disposed | 2029-01-10 | Common Stock (6000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 69283 | Indirect |
Footnotes
F1: Excludes 1,281 shares previously reported as owned directly which have been transferred to the Robert A Schueren & Deborah A Schueren Rev Trust.
F2: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2021.
F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The Reporting Person is a trustee of the Robert A Schueren & Deborah A Schueren Rev Trust, and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F5: The option shares vest over four years. 25% of the option shares vested and became exercisable on January 7, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.